Registration Timeline Planning for Medical Devices in Indonesia

1. Key takeaways

The gap between the official assessment clock and the real end-to-end duration of an Indonesian registration is substantial. The official clock covers only the assessment segment, at 21, 36, 36 and 55 working days for Classes A through D respectively, while the full journey must also absorb licence holder qualification readiness, document notarisation and legalisation, translation and localisation, possible local testing, queueing and system processing, and deficiency round-trips. Industry experience values place the end-to-end duration at approximately 1-2 months for Class A, 3-5 months for Classes B and C, and 5-7 months for Class D. Planning that ignores this gap, or that starts the project at the moment of preparing shipment rather than the moment of deciding to enter Indonesia, is the most common source of missed launch dates and goods stranded at port. The remedy is structural rather than heroic: a plan built from the correct segments, started early enough, leaves almost no room for the surprises that derail late-started projects.

• Official assessment clocks cover assessment only: 21, 36, 36 and 55 working days for Classes A, B, C and D.
• End-to-end duration adds qualifications, legalisation, translation, local testing, queueing and deficiency round-trips.
• Industry experience values: Class A approximately 1-2 months, Class B/C approximately 3-5 months, Class D approximately 5-7 months.
• Six-segment time budget: classification and pathway determination, licence holder readiness, document preparation and legalisation, CSDT dossier writing, assessment and deficiencies, post-certificate actions.
• For first-time entrants the critical path is document legalisation and licence holder qualifications; for companies with an existing licence holder it shifts to dossier quality.
• There is no public mechanism in Indonesia that buys speed with money; compression comes from parallelisation, qualification-ready licence holders and first-time-right dossiers.

2. Legal basis

The assessment timelines referenced throughout the planning exercise are those of Annex 3 of Permenkes No. 11/2025, giving 21, 36, 36 and 55 working days for new registrations in Classes A through D. The licence holder prerequisites, namely the IDAK and CDAKB, are regulated under Permenkes No. 14/2021, and the time needed to obtain them sits entirely outside the official clock, which is why a licence holder who already holds them changes the project’s critical path. On document legalisation, the entry into force of the Hague Apostille Convention for Indonesia on June 4, 2022 affects the legalisation cycle for LoA, CFS and ISO 13485 documents, and the duration still varies with the country and embassy processes involved. The end-to-end figures quoted in this article, including the six-segment budget ranges of 1-2 weeks, 4-8 weeks and 1-4 weeks, are industry experience values and are marked as such throughout; they are a practical estimate, not an official commitment.

3. Expert insights

The six-segment time budget is the core planning tool. Segment one is classification and pathway determination, taking 1-2 weeks. Segment two is licence holder qualification readiness: zero time where the holder is already qualified, but several months for a newly established company or a licence change. Segment three is document preparation and legalisation, covering the LoA, CFS and ISO 13485 with notarisation, legalisation and translation, at 4-8 weeks depending on the country and embassy processes. Segment four is dossier writing to the CSDT structure, at 4-8 weeks depending on risk class and data completeness. Segment five is assessment and deficiencies, the official clock plus deficiency round-trips. Segment six is the post-certificate actions, namely the KFA code, e-Katalog listing and per-batch SKI, each taking 1-4 weeks. The critical path follows the segment analysis: for companies entering Indonesia for the first time, it lies in segment three, document legalisation, and segment two, licence holder qualifications, both of which sit entirely outside the official clock and are the most likely to drift. For companies that already have a qualified licence holder, the critical path shifts to segment four, because dossier quality directly determines how many deficiency rounds the file consumes. On compression, three levers exist: parallelisation, starting document legalisation and CSDT writing simultaneously rather than serially; selecting a licence holder with existing qualifications, which saves the IDAK and CDAKB acquisition time; and doing it right the first time, using the four-way alignment check described in the dedicated article of this series to push deficiencies to zero rounds. The monetary lever of paying an expedite fee has no public mechanism in Indonesia. Read together, the segments and the levers give a portfolio owner a reliable way to answer the only question that matters commercially: when can this product realistically be sold in Indonesia, stated as a range the regulatory evidence can actually support.

4. Practical recommendations

• Start the registration project at the moment of deciding to enter Indonesia, not at the moment of preparing shipment; for Class C and Class D products, the preparation of clinical evidence and local testing alone can consume half a year.
• Build the project plan on the six-segment budget rather than on the official clock, and track each segment with its own owner and dates.
• Run document legalisation and CSDT writing in parallel from the outset instead of sequencing them.
• Prefer a licence holder who already holds the IDAK and CDAKB, eliminating the months-long qualification acquisition from the critical path.
• Apply the four-way alignment check across the LoA, CFS, CSDT and label to drive deficiency rounds toward zero.
• Set the sales commitment date as the end-to-end baseline multiplied by 1.3, and state explicitly that it excludes local testing and verification, since warehousing fees from goods stranded at port without a certificate usually far exceed the cost of starting the project three months earlier.

5. Verification checklist

• □ Permenkes No. 11/2025 Annex 3 assessment timelines.
• □ Permenkes No. 14/2021 for the IDAK and CDAKB prerequisites.
• □ Entry into force of the Hague Apostille Convention for Indonesia on June 4, 2022, affecting document legalisation cycles.
• □ End-to-end durations are industry experience values, marked as such and pending verification against each project’s circumstances.
• □ Data verified as of October 26, 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Indonesia. Our team prepares dossiers to ASEAN CSDT structure, manages AKL/AKL-I submissions with Kemenkes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com